Literature DB >> 14719182

Association between a variant of the glutathione S-transferase P1 gene (GSTP1) and hypertension in pregnancy in Japanese: interaction with parity, age, and genetic factors.

Kaori Ohta1, Gen Kobashi, Akira Hata, Hideto Yamada, Hisanori Minakami, Seiichiro Fujimoto, Kiyotaro Kondo, Hidehiko Tamashiro.   

Abstract

Hypertension in pregnancy (HP), including preeclampsia (PE), is known to be a multifactorial disease. Recently, an Ile105Val variant of the glutathione S-transferase P1 gene ( GSTP1) was shown to be associated with PE in The Netherlands. We therefore performed an association study of the Ile105Val variant comparing 131 patients with HP and 327 normal pregnant controls in Japan. We analyzed the data in the context of other risk factors before pregnancy. The frequency of the Ile/Val+Val/Val genotype of the GSTP1 was not significantly different between the HP (26%) patients and the controls (28%). However, in primiparous patients, the frequency was significantly different in elderly pregnancy (63% in severe HP vs. 18% in controls; P < 0.05), in the subgroup with the MM+MT genotypes of the angiotensinogen gene (50% in severe HP vs. 26% in controls; P < 0.05), and in the subgroup with the GA+AA genotypes of the endothelial nitric oxide synthase gene (42% in severe HP vs. 13% in controls; P < 0.05). These results suggest that this variant of the GSTP1 may play a role in the manifestation of HP together with other independently and/or synergistically acting factors, particularly in primiparous pregnancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14719182     DOI: 10.1055/s-2004-815636

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  6 in total

1.  Genetic polymorphisms of glutathione S-transferase Z1 (GSTZ1) and susceptibility to preeclampsia.

Authors:  Mostafa Saadat; Zahra Anvar; Bahia Namavar-Jahromi; Iraj Saadat
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

2.  Variable effects of maternal and paternal-fetal contribution to the risk for preeclampsia combining GSTP1, eNOS, and LPL gene polymorphisms.

Authors:  Kalliopi I Pappa; Maria Roubelakis; George Vlachos; Spyros Marinopoulos; Antonia Zissou; Nicholas P Anagnou; Aris Antsaklis
Journal:  J Matern Fetal Neonatal Med       Date:  2010-09-14

Review 3.  The genetics of pre-eclampsia and other hypertensive disorders of pregnancy.

Authors:  Paula J Williams; Fiona Broughton Pipkin
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-03-22       Impact factor: 5.237

4.  Annual body mass index gain and risk of hypertensive disorders of pregnancy in a subsequent pregnancy.

Authors:  Sho Tano; Tomomi Kotani; Takafumi Ushida; Masato Yoshihara; Kenji Imai; Tomoko Nakano-Kobayashi; Yoshinori Moriyama; Yukako Iitani; Fumie Kinoshita; Shigeru Yoshida; Mamoru Yamashita; Yasuyuki Kishigami; Hidenori Oguchi; Hiroaki Kajiyama
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

5.  Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis.

Authors:  Christina K H Yu; Juan P Casas; Makrina D Savvidou; Manpreet K Sahemey; Kypros H Nicolaides; Aroon D Hingorani
Journal:  BMC Pregnancy Childbirth       Date:  2006-03-16       Impact factor: 3.007

6.  4G/5G variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase.

Authors:  Gen Kobashi; Kaori Ohta; Hideto Yamada; Akira Hata; Hisanori Minakami; Noriaki Sakuragi; Hiko Tamashiro; Seiichiro Fujimoto
Journal:  J Epidemiol       Date:  2009-10-17       Impact factor: 3.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.